Clinical Neuropharmacology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.2 | Q4 | 15.9% | 0.422 | Q3 | 55.1% |
| 2024 | 1.5 | Q4 | 25.3% | 0.326 | Q3 | 48.3% |
| 2023 | 0.8 | Q4 | 14.5% | 0.287 | Q3 | 47.6% |
| 2022 | 1.0 | Q4 | 15.8% | 0.293 | Q3 | 49.9% |
| 2021 | 1.4 | Q4 | 31.4% | 0.334 | Q3 | 54.8% |
| 2020 | — | — | 0.486 | Q3 | 65.4% | |
| 2019 | — | — | 0.440 | Q3 | 63.7% | |
| 2018 | — | — | 0.509 | Q3 | 65.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0362-5664
ISSN
1537-162X
country
UScoverage
1982-2026